Reading Time: 4 minutesIn Chicago, it’s the beginning of the third day of the International Symposium on ALS/MND. I feel that I’ve become almost institutionalised: I get up,
Tag: International Symposium on ALS/MND
Reading Time: 3 minutesA very much ‘must report on’ session of the 23rd International Symposium on ALS/MND was the clinical trials and trial design session. There are many
Reading Time: 3 minutesThe symposium session ‘Carer and Family Support’ provided a platform to better understand the role that informal carers play in the lives of people with
Reading Time: 3 minutesTrying to understand what the different underlying factors are towards developing MND has always been a goal for ALS research. MND Association funded researcher and
Reading Time: < 1 minuteNovember has been an incredibly busy time for us, not because of Christmas, but because the 23rd International Symposium on ALS/MND is now only one week away!
Reading Time: 3 minutesPromising results from a Phase II clinical trial for a drug called NP001 have been announced by the biopharmaceutical company Neuraltus. The trial, conducted in America, suggested
Reading Time: 2 minutesWe organise the International Symposium on ALS/MND every year, and it is regarded as the premier medical conference on MND and a highlight of the
Reading Time: < 1 minuteAttending a three day scientific meeting is quite an intense experience, my brain has been working hard and by this morning, there were leaks of
Reading Time: 3 minutesModels of MND are important both to understand the causes of MND and to quickly, efficiently and accurately screen and develop new treatments for it.
Reading Time: 3 minutes“After a time where patients and sponsors of trials alike had become disheartened about the lack of positive clinical trials, it is exciting to see